A trio of recent studies indicates that pancreatic cancer is, in some cases, linked to mutations passed down from generation to generation.
by Cheryl Platzman Weinstock
The National Cancer Institute’s Todd Horowitz discusses cancer-related cognitive impairment.
by Anna Azvolinsky
Two studies identify genetic mutations that could predict the risk of an aggressive blood cancer up to a decade before it is diagnosed.
Eating ultraprocessed foods may be linked to an increased risk of certain cancers.
by Kendall Morgan
From the Editor-in-Chief
Insights about synthetic lethality have been used to develop cancer treatments.
by William G. Nelson, MD, PhD
Pathologists and radiologists are leading the way in the use of artificial intelligence (AI) to find and track cancer. Machine learning could lay the foundation for using AI more broadly to advance cancer diagnosis and choice of treatment.
by Stephen Ornes
Cancer has a disproportionate impact on disadvantaged and minority groups. The AACR 2020 by 2020 initiative is a step toward closing the gap.
by Michael A. Caligiuri, MD
Neurosurgeon Frederick F. Lang discusses virus-powered cancer treatments.
by Sue Rochman
Including patients with HIV is part of a larger effort to broaden cancer clinical trial eligibility.
by Andy Kopsa
Research findings could help improve personalized treatments for lung cancer patients.
Researchers suggest reclassification of low-risk cancers, and an immunotherapy drug is approved for small cell lung cancer.
by Kate Yandell
Organizations work to broaden eligibility for cancer clinical trials, and an article explores the limitations of personalized mouse models.
As a father with an aggressive brain cancer, I’ve opted against elaborate metaphors and in favor of candid speech when talking about cancer with my children.
by Adam Hayden
A program helps cancer survivors start gardens as a way to increase their vegetable consumption and physical activity.
by Ashley P. Taylor
Liquid biopsy, which is often performed using a simple blood draw, can tell scientists about cancer DNA in the blood.
The U.S. Food and Drug Administration has approved new treatments for several rare cancers.
Analysis of cancer death data in New York state revealed high cancer mortality rates among some minority subpopulations.
Editor-in-Chief William G. Nelson Discusses Cancer Today
donate to the AACR